Video about National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation

National Medical Research Radiological Centreof the Ministry of Health of the Russian Federation today is one of the largest oncological and radiological clusters in Russia, the leading institution in radiology, a reference center in the field of pathomorphological research and radiation diagnostics and therapy. Since 2020 it is also the base organization of the CIS member states in the field of oncology.

Two national registers operate on the basis of National Medical Research Center of Radiology of the Ministry of Health of Russia: Cancer – register and the National Radiation – Epidemiological Register.

The Center has a full range of modern diagnostics and complex and combined methods of treatment of cancer patients. The center has in its arsenal all types of modern beam installations, including Gamma and Cyber knives, the first Russian made proton accelerator “Prometheus”. Center implements such innovative technologies such as HIPEC and PIPAC, X-ray surgical methods of treatment, radionuclide and brachytherapy.

The Center has patented and is actively applying a method for preserving the reproductive functions of cancer patients using cryopreservation of genetic material.

A unique for Russia department of reconstructive plastic surgery of radiation injuries has been created.

The Center is one of the leaders in the field of Nuclear Medicine, development of Russian radiopharmaceuticals and their implementation in clinical practice. Nuclear medicine technologies in combined and complex treatment provide significant / additional therapeutic benefits for both oncological and non-oncological diseases.

The Pharmacy manufactures innovative radiopharmaceuticals based on 188Re, 177Lu and 225Ac radionuclides developed at the Center for the treatment of metastatic prostate cancer, primary and metastatic liver cancer, metastatic skeletal lesions and knee joint chronic synovitis.

It is planned to manufacture radiopharmaceuticals for the treatment of neuroendocrine malignant neoplasms, non-Hodgkin’s lymphoma, etc. GMP- research and production center produces biotechnological drugs: CAR-T cells, stem cells, oncolytic and mRNA vaccines, opening new horizons in  oncological and oncohematological diseases treatment.